Boston Scientific(US:BSX) ZACKS·2025-12-12 00:01Company Performance - Boston Scientific's stock was down 1.02% at $91.75, underperforming the S&P 500's daily gain of 0.21% and the Dow's increase of 1.35% [1] - Over the past month, shares of Boston Scientific have decreased by 10.98%, contrasting with the Medical sector's gain of 3.7% and the S&P 500's gain of 0.89% [1] Upcoming Earnings - Analysts expect Boston Scientific to report earnings of $0.78 per share, indicating a year-over-year growth of 11.43% [2] - The consensus estimate projects revenue of $5.27 billion, reflecting a 15.46% increase from the same quarter last year [2] Annual Estimates - For the annual period, earnings are anticipated to be $3.04 per share and revenue is expected to reach $20.06 billion, representing increases of 21.12% and 19.77% respectively from the previous year [3] - Recent adjustments to analyst estimates suggest a favorable outlook on Boston Scientific's business health and profitability [3] Valuation Metrics - Boston Scientific is currently trading at a Forward P/E ratio of 30.54, which is higher than the industry average of 19.41, indicating a premium valuation [6] - The company has a PEG ratio of 1.87, compared to the industry average PEG ratio of 1.95 [7] Industry Ranking - The Medical - Products industry, which includes Boston Scientific, has a Zacks Industry Rank of 165, placing it within the bottom 34% of over 250 industries [8] - The Zacks Industry Rank evaluates the performance of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [8]